|
OMIM |
Link |
Information gain |
01 |
|
trichorrhexis nodosa syndrome
|
[NCBI]
|
0.00160371
|
|
|
ETL2
|
[NCBI]
|
0.00160371
|
|
|
folic acid, transport defect involving
|
[NCBI]
|
0.00141158
|
|
|
storage pool platelet disease
|
[NCBI]
|
0.00128562
|
|
|
stomatocytosis i
|
[NCBI]
|
0.0011173
|
|
|
SLC6A3
|
[NCBI]
|
0.000551258
|
|
|
refsum disease
|
[NCBI]
|
0.000228931
|
|
|
XPA
|
[NCBI]
|
0.000215391
|
|
|
SLC6A4
|
[NCBI]
|
0.000194948
|
|
|
cyclic hematopoiesis
|
[NCBI]
|
0.000194003
|
|
|
EGF
|
[NCBI]
|
0.000171271
|
|
|
LNS
|
[NCBI]
|
0.000170892
|
|
|
mucopolysaccharidosis type iiic
|
[NCBI]
|
0.000162489
|
|
|
AIS
|
[NCBI]
|
0.000159667
|
|
|
virus rd114 rna complementarity
|
[NCBI]
|
0.000144517
|
|
|
lymphoblastic transformation, inhibition of
|
[NCBI]
|
0.000144517
|
|
|
CPI
|
[NCBI]
|
0.000143211
|
|
|
krabbe disease
|
[NCBI]
|
0.000138591
|
|
|
CES
|
[NCBI]
|
0.000117171
|
|
|
breast cancer
|
[NCBI]
|
0.000105501
|
|
|
CDSP
|
[NCBI]
|
9.80406e-05
|
|
|
SLS
|
[NCBI]
|
9.47574e-05
|
|
|
fragile site 2q11
|
[NCBI]
|
9.33785e-05
|
|
|
de sanctis-cacchione syndrome
|
[NCBI]
|
8.76606e-05
|
|
|
hematopoietic stem cell kinetics, control of
|
[NCBI]
|
8.76606e-05
|
|
|
SLC18A3
|
[NCBI]
|
8.68479e-05
|
|
|
XPB
|
[NCBI]
|
7.93362e-05
|
|
|
XPV
|
[NCBI]
|
6.85537e-05
|
|
|
FAAH
|
[NCBI]
|
6.73207e-05
|
|
|
VEGF
|
[NCBI]
|
6.68358e-05
|
|
|
chloramphenicol toxicity
|
[NCBI]
|
6.65192e-05
|
|
|
sulfocysteinuria
|
[NCBI]
|
6.4658e-05
|
|
|
cystathioninuria
|
[NCBI]
|
6.29433e-05
|
|
|
APOF
|
[NCBI]
|
6.13542e-05
|
|
|
alpha-methylacetoacetic aciduria
|
[NCBI]
|
5.98739e-05
|
|
|
17-@beta hydroxysteroid dehydrogenase iii deficiency
|
[NCBI]
|
5.98739e-05
|
|
|
coumarin resistance
|
[NCBI]
|
5.98739e-05
|
|
|
ehlers-danlos syndrome, type vi
|
[NCBI]
|
5.84887e-05
|
|
|
corticosterone methyloxidase type ii deficiency
|
[NCBI]
|
5.84887e-05
|
|
|
hodgkin lymphoma
|
[NCBI]
|
5.71874e-05
|
|
|
MEN2B
|
[NCBI]
|
5.71874e-05
|
|
|
EKV
|
[NCBI]
|
5.48009e-05
|
|
|
gilbert syndrome
|
[NCBI]
|
5.48009e-05
|
|
|
acyl-coa dehydrogenase, very long-chain, deficiency of
|
[NCBI]
|
5.3701e-05
|
|
|
sitosterolemia
|
[NCBI]
|
5.3701e-05
|
|
|
hepatitis c virus, susceptibility to
|
[NCBI]
|
5.16592e-05
|
|
|
propionic acidemia
|
[NCBI]
|
4.97984e-05
|
|
|
lecithin:cholesterol acyltransferase deficiency
|
[NCBI]
|
4.97984e-05
|
|
|
RA
|
[NCBI]
|
4.91061e-05
|
|
|
infantile sialic acid storage disorder
|
[NCBI]
|
4.89266e-05
|
|
|
sialuria, finnish type
|
[NCBI]
|
4.89266e-05
|
|
|
CHAT
|
[NCBI]
|
4.84092e-05
|
|
|
KLK3
|
[NCBI]
|
4.72981e-05
|
|
|
ED1
|
[NCBI]
|
4.65117e-05
|
|
|
CEL
|
[NCBI]
|
4.55814e-05
|
|
|
TSD
|
[NCBI]
|
4.5469e-05
|
|
|
methylmalonic aciduria due to methylmalonyl-coa mutase deficiency
|
[NCBI]
|
4.5046e-05
|
|
|
LPL
|
[NCBI]
|
4.45647e-05
|
|
|
PPSH
|
[NCBI]
|
4.43508e-05
|
|
|
TNF
|
[NCBI]
|
4.34747e-05
|
|
|
DCK
|
[NCBI]
|
4.22274e-05
|
|
|
EGFR
|
[NCBI]
|
4.19931e-05
|
|
|
HRH4
|
[NCBI]
|
4.19776e-05
|
|
|
DJS
|
[NCBI]
|
3.89836e-05
|
|
|
OPRM1
|
[NCBI]
|
3.57432e-05
|
|
|
HNMT
|
[NCBI]
|
3.45104e-05
|
|
|
SMA1
|
[NCBI]
|
3.3948e-05
|
|
|
FPGS
|
[NCBI]
|
3.37025e-05
|
|
|
APOB
|
[NCBI]
|
3.36493e-05
|
|
|
galactosemia
|
[NCBI]
|
3.20365e-05
|
|
|
HPRT1
|
[NCBI]
|
3.15556e-05
|
|
|
protein kinase d2
|
[NCBI]
|
3.11792e-05
|
|
|
CVID
|
[NCBI]
|
3.11713e-05
|
|
|
ABCC8
|
[NCBI]
|
3.07945e-05
|
|
|
PNMT
|
[NCBI]
|
3.0415e-05
|
|
|
CEACAM5
|
[NCBI]
|
3.0085e-05
|
|
|
CRH
|
[NCBI]
|
2.94717e-05
|
|
|
COMT
|
[NCBI]
|
2.90624e-05
|
|
|
ABCC3
|
[NCBI]
|
2.63106e-05
|
|
|
SLC1A1
|
[NCBI]
|
2.63106e-05
|
|
|
thrombasthenia of glanzmann and naegeli
|
[NCBI]
|
2.54231e-05
|
|
|
SERPINA6
|
[NCBI]
|
2.44474e-05
|
|
|
GPR88
|
[NCBI]
|
2.37716e-05
|
|
|
TRN
|
[NCBI]
|
2.37716e-05
|
|
|
ACHE
|
[NCBI]
|
2.30552e-05
|
|
|
fragile x mental retardation syndrome
|
[NCBI]
|
2.26619e-05
|
|
|
TYMS
|
[NCBI]
|
2.25799e-05
|
|
|
CCK
|
[NCBI]
|
2.25185e-05
|
|
|
DGS
|
[NCBI]
|
2.18365e-05
|
|
|
MN
|
[NCBI]
|
2.18364e-05
|
|
|
SRC
|
[NCBI]
|
2.18116e-05
|
|
|
HDC
|
[NCBI]
|
2.13871e-05
|
|
|
MPO
|
[NCBI]
|
2.12174e-05
|
|
|
TRG1
|
[NCBI]
|
2.09855e-05
|
|
|
SLCO1B3
|
[NCBI]
|
2.09855e-05
|
|
|
HRH3
|
[NCBI]
|
2.09855e-05
|
|
|
SLC22A16
|
[NCBI]
|
2.09855e-05
|
|
|
fabry disease
|
[NCBI]
|
2.03051e-05
|
|
|
CAT
|
[NCBI]
|
2.02136e-05
|
|
|
AR
|
[NCBI]
|
1.99773e-05
|
|
|
FXYD1
|
[NCBI]
|
1.94633e-05
|
|
|
PEMT
|
[NCBI]
|
1.92329e-05
|
|
|
PIGB
|
[NCBI]
|
1.91818e-05
|
|
|
TRNP3
|
[NCBI]
|
1.91818e-05
|
|
|
BZRP
|
[NCBI]
|
1.91818e-05
|
|
|
HTR1D
|
[NCBI]
|
1.91818e-05
|
|
|
hemoglobin--alpha locus 3
|
[NCBI]
|
1.91818e-05
|
|
|
COPB
|
[NCBI]
|
1.91818e-05
|
|
|
SMAX1
|
[NCBI]
|
1.89129e-05
|
|
|
TH
|
[NCBI]
|
1.84892e-05
|
|
|
FBXL2
|
[NCBI]
|
1.78446e-05
|
|
|
GABRA6
|
[NCBI]
|
1.78446e-05
|
|
|
SLC22A9
|
[NCBI]
|
1.78446e-05
|
|
|
OMP
|
[NCBI]
|
1.78006e-05
|
|
|
FGR
|
[NCBI]
|
1.67822e-05
|
|
|
WFDC1
|
[NCBI]
|
1.67822e-05
|
|
|
SLC29A2
|
[NCBI]
|
1.67822e-05
|
|
|
CYP2R1
|
[NCBI]
|
1.67822e-05
|
|
|
CYP1A1
|
[NCBI]
|
1.67731e-05
|
|
|
GPR68
|
[NCBI]
|
1.59014e-05
|
|
|
ABCC1
|
[NCBI]
|
1.51996e-05
|
|
|
PTGFR
|
[NCBI]
|
1.51496e-05
|
|
|
GPR4
|
[NCBI]
|
1.51496e-05
|
|
|
LCAT
|
[NCBI]
|
1.51159e-05
|
|
|
ANGPTL3
|
[NCBI]
|
1.44944e-05
|
|
|
AVPR1A
|
[NCBI]
|
1.44944e-05
|
|
|
SLC18A1
|
[NCBI]
|
1.3914e-05
|
|
|
panencephalitis, subacute sclerosing
|
[NCBI]
|
1.38365e-05
|
|
|
HTR1B
|
[NCBI]
|
1.33935e-05
|
|
|
PICK1
|
[NCBI]
|
1.33935e-05
|
|
|
ATP8B1
|
[NCBI]
|
1.33935e-05
|
|
|
HTR1A
|
[NCBI]
|
1.29219e-05
|
|
|
ichthyosis, x-linked
|
[NCBI]
|
1.25061e-05
|
|
|
PAPSS2
|
[NCBI]
|
1.2491e-05
|
|
|
HLA-A
|
[NCBI]
|
1.21946e-05
|
|
|
GABRA1
|
[NCBI]
|
1.20945e-05
|
|
|
RNR1
|
[NCBI]
|
1.17276e-05
|
|
|
SLC27A1
|
[NCBI]
|
1.17276e-05
|
|
|
NMB
|
[NCBI]
|
1.15118e-05
|
|
|
SLCO2A1
|
[NCBI]
|
1.13862e-05
|
|
|
SLOS
|
[NCBI]
|
1.11568e-05
|
|
|
ERCC3
|
[NCBI]
|
1.10671e-05
|
|
|
ALOX5AP
|
[NCBI]
|
1.10671e-05
|
|
|
FLG
|
[NCBI]
|
1.10671e-05
|
|
|
LRAT
|
[NCBI]
|
1.10671e-05
|
|
|
IL9
|
[NCBI]
|
1.07678e-05
|
|
|
ABCB11
|
[NCBI]
|
1.06297e-05
|
|
|
tyrosine transaminase deficiency
|
[NCBI]
|
1.02199e-05
|
|
|
HBZ
|
[NCBI]
|
1.02199e-05
|
|
|
ACADVL
|
[NCBI]
|
9.96795e-06
|
|
|
DHFR
|
[NCBI]
|
9.82273e-06
|
|
|
LRP2
|
[NCBI]
|
9.72872e-06
|
|
|
MAP4
|
[NCBI]
|
9.5011e-06
|
|
|
CFTR
|
[NCBI]
|
9.33947e-06
|
|
|
TK1
|
[NCBI]
|
9.28407e-06
|
|
|
GFAP
|
[NCBI]
|
9.28226e-06
|
|
|
TG
|
[NCBI]
|
9.27461e-06
|
|
|
NGFB
|
[NCBI]
|
8.8089e-06
|
|
|
GDXY
|
[NCBI]
|
8.33029e-06
|
|
|
AQP5
|
[NCBI]
|
8.16146e-06
|
|
|
CAV1
|
[NCBI]
|
7.9988e-06
|
|
|
CES1
|
[NCBI]
|
7.9988e-06
|
|
|
PLD2
|
[NCBI]
|
7.9988e-06
|
|
|
RYR2
|
[NCBI]
|
7.84189e-06
|
|
|
SLC22A6
|
[NCBI]
|
7.84189e-06
|
|
|
SLC3A2
|
[NCBI]
|
7.84189e-06
|
|
|
SLE
|
[NCBI]
|
7.83627e-06
|
|
|
RBP1
|
[NCBI]
|
7.61265e-06
|
|
|
RBP3
|
[NCBI]
|
7.54396e-06
|
|
|
DDOST
|
[NCBI]
|
7.54396e-06
|
|
|
F3
|
[NCBI]
|
7.36346e-06
|
|
|
FGF7
|
[NCBI]
|
7.34755e-06
|
|
|
ADH5
|
[NCBI]
|
7.26516e-06
|
|
|
ALDH3A2
|
[NCBI]
|
7.26516e-06
|
|
|
DNAJC5
|
[NCBI]
|
7.13226e-06
|
|
|
PIGA
|
[NCBI]
|
7.00338e-06
|
|
|
PTX3
|
[NCBI]
|
7.00338e-06
|
|
|
KAL1
|
[NCBI]
|
6.75686e-06
|
|
|
DBI
|
[NCBI]
|
6.66021e-06
|
|
|
EPO
|
[NCBI]
|
6.20868e-06
|
|
|
PDYN
|
[NCBI]
|
6.19792e-06
|
|
|
PNPLA6
|
[NCBI]
|
6.17069e-06
|
|
|
SLC16A1
|
[NCBI]
|
6.09477e-06
|
|
|
SLC6A6
|
[NCBI]
|
6.09477e-06
|
|
|
ABCG2
|
[NCBI]
|
6.08599e-06
|
|
|
PTH
|
[NCBI]
|
6.03706e-06
|
|
|
AVP
|
[NCBI]
|
6.01348e-06
|
|
|
CYP17A1
|
[NCBI]
|
5.80044e-06
|
|
|
SHBG
|
[NCBI]
|
5.58369e-06
|
|
|
HRAS
|
[NCBI]
|
5.52664e-06
|
|
|
IGHG1
|
[NCBI]
|
5.35435e-06
|
|
|
RLBP1
|
[NCBI]
|
5.03171e-06
|
|
|
PLTP
|
[NCBI]
|
4.68776e-06
|
|
|
porphyria cutanea tarda
|
[NCBI]
|
4.66453e-06
|
|
|
SLC18A2
|
[NCBI]
|
4.52759e-06
|
|
|
RNASE3
|
[NCBI]
|
4.39001e-06
|
|
|
SST
|
[NCBI]
|
4.31672e-06
|
|
|
MDD
|
[NCBI]
|
4.26542e-06
|
|
|
GCCR
|
[NCBI]
|
4.14649e-06
|
|
|
CF
|
[NCBI]
|
3.95022e-06
|
|
|
TF
|
[NCBI]
|
3.90483e-06
|
|
|
PENK
|
[NCBI]
|
3.85891e-06
|
|
|
CD36
|
[NCBI]
|
3.80432e-06
|
|
|
RYR1
|
[NCBI]
|
3.69786e-06
|
|
|
B2M
|
[NCBI]
|
3.64594e-06
|
|
|
F2R
|
[NCBI]
|
3.64594e-06
|
|
|
PGR
|
[NCBI]
|
3.60247e-06
|
|
|
temporal arteritis
|
[NCBI]
|
3.56258e-06
|
|
|
BTK
|
[NCBI]
|
3.49519e-06
|
|
|
APOA1
|
[NCBI]
|
3.25945e-06
|
|
|
UGB
|
[NCBI]
|
3.17017e-06
|
|
|
HEXA
|
[NCBI]
|
3.17017e-06
|
|
|
mucopolysaccharidosis type ii
|
[NCBI]
|
3.17017e-06
|
|
|
MEN1
|
[NCBI]
|
3.12654e-06
|
|
|
HGF
|
[NCBI]
|
3.0112e-06
|
|
|
LCT
|
[NCBI]
|
2.91792e-06
|
|
|
SCD
|
[NCBI]
|
2.54335e-06
|
|
|
thrombocytopenic purpura, autoimmune
|
[NCBI]
|
2.50718e-06
|
|
|
ABCC2
|
[NCBI]
|
2.37475e-06
|
|
|
hla-d histocompatibility type
|
[NCBI]
|
2.33885e-06
|
|
|
FRAP1
|
[NCBI]
|
2.30351e-06
|
|
|
homocystinuria
|
[NCBI]
|
2.27892e-06
|
|
|
SI
|
[NCBI]
|
2.15693e-06
|
|
|
AFP
|
[NCBI]
|
1.84637e-06
|
|
|
POMC
|
[NCBI]
|
1.77577e-06
|
|
|
TFPI
|
[NCBI]
|
1.73708e-06
|
|
|
NPY
|
[NCBI]
|
1.71911e-06
|
|
|
HBA1
|
[NCBI]
|
1.67668e-06
|
|
|
GAPDH
|
[NCBI]
|
1.51909e-06
|
|
|
DDC
|
[NCBI]
|
1.436e-06
|
|
|
HBA2
|
[NCBI]
|
1.41545e-06
|
|
|
STAT5A
|
[NCBI]
|
1.29718e-06
|
|
|
GC
|
[NCBI]
|
1.22292e-06
|
|
|
TLR4
|
[NCBI]
|
1.16482e-06
|
|
|
VASP
|
[NCBI]
|
1.13493e-06
|
|
|
VDR
|
[NCBI]
|
1.11181e-06
|
|
|
SLC2A4
|
[NCBI]
|
1.10118e-06
|
|
|
NGFR
|
[NCBI]
|
1.06821e-06
|
|
|
MBP
|
[NCBI]
|
9.27944e-07
|
|
|
APOE
|
[NCBI]
|
9.21361e-07
|
|
|
PCNA
|
[NCBI]
|
8.16544e-07
|
|
|
DNMT1
|
[NCBI]
|
7.91188e-07
|
|
|
HP
|
[NCBI]
|
7.40305e-07
|
|
|
PPARA
|
[NCBI]
|
7.19861e-07
|
|
|
APP
|
[NCBI]
|
7.1598e-07
|
|
|
GDNF
|
[NCBI]
|
6.80905e-07
|
|
|
PMP22
|
[NCBI]
|
6.68785e-07
|
|
|
G6PD
|
[NCBI]
|
6.51325e-07
|
|
|
adrenal hyperplasia, congenital, due to 21-hydroxylase deficiency
|
[NCBI]
|
6.23833e-07
|
|
|
GNRH1
|
[NCBI]
|
5.75961e-07
|
|
|
NPPA
|
[NCBI]
|
5.56341e-07
|
|
|
FMR1
|
[NCBI]
|
4.6475e-07
|
|
|
PTHLH
|
[NCBI]
|
4.64743e-07
|
|
|
PTK2
|
[NCBI]
|
4.63565e-07
|
|
|
ACE
|
[NCBI]
|
4.29631e-07
|
|
|
GAL
|
[NCBI]
|
3.89983e-07
|
|
|
KCNH2
|
[NCBI]
|
3.88554e-07
|
|
|
XDH
|
[NCBI]
|
3.52483e-07
|
|
|
CNTF
|
[NCBI]
|
2.48994e-07
|
|
|
TTR
|
[NCBI]
|
2.28445e-07
|
|
|
FA
|
[NCBI]
|
2.1183e-07
|
|
|
VIP
|
[NCBI]
|
1.50011e-07
|
|
|
ACPP
|
[NCBI]
|
1.28831e-07
|
|
|
CP
|
[NCBI]
|
1.25814e-07
|
|
|
PF4
|
[NCBI]
|
1.1317e-07
|
|
|
CDK2
|
[NCBI]
|
1.02194e-07
|
|
|
PRL
|
[NCBI]
|
8.07033e-08
|
|
|
ADCYAP1
|
[NCBI]
|
5.99561e-08
|
|
|
STAT3
|
[NCBI]
|
3.7383e-08
|
|
|
MG
|
[NCBI]
|
3.3543e-08
|
|
|
IL2
|
[NCBI]
|
3.26467e-08
|
|
|
INS
|
[NCBI]
|
3.23341e-08
|
|
|
PMCH
|
[NCBI]
|
2.18942e-08
|
|
|
AHR
|
[NCBI]
|
1.63286e-08
|
|
|
BDNF
|
[NCBI]
|
1.60411e-08
|
|
|
BCHE
|
[NCBI]
|
1.44835e-08
|
|
|
AKR1B1
|
[NCBI]
|
1.15119e-08
|
|
|
ALB
|
[NCBI]
|
1.03858e-08
|
|
|
ADA
|
[NCBI]
|
4.52039e-09
|
|
|
ADM
|
[NCBI]
|
3.25543e-09
|
|
|
HBB
|
[NCBI]
|
1.56724e-09
|
|
|
AD
|
[NCBI]
|
4.72738e-10
|
|
|
PYY
|
[NCBI]
|
1.76872e-11
|
|